Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Report
0 Followers
MX:VRTX Q3 2022 EPS Results
- Actual EPS
- MXN 74.69
- Consensus EPS
- MXN 67.29
- Beat/Miss
- Beat by +MXN 7.39
- One Year Ago EPS
- MXN 66.31
MX:VRTX Q3 2022 Revenue Results
- Actual Revenue
- MXN 42.26B
- Expected Revenue
- MXN 41.54B
- Beat/Miss
- Beat by +MXN 727.90M
- YoY Revenue Growth
- +14.06%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 10/27/2022
- Time
- After Close
- Conference Call
- Thursday, October 27, 2022
MX:VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
MX:VRTX Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 78.13- | 93.69 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 89.7288.66 | 89.4 | -0.83% (-0.75) | |
| Aug 03, 2026 | 2026 (Q2) | 88.3088.10 | 84.19 | 4.65% (+3.91) | |
| May 04, 2026 | 2026 (Q1) | 79.0383.26 | 75.62 | 10.10% (+7.64) | |
| Feb 12, 2026 | 2025 (Q4) | 95.1993.69 | 74.13 | 26.38% (+19.56) | |
| Nov 03, 2025 | 2025 (Q3) | 85.1789.40 | 81.58 | 9.59% (+7.82) | |
| Aug 06, 2025 | 2025 (Q2) | 79.8784.19 | -238.96 | 135.23% (+323.15) | |
| May 05, 2025 | 2025 (Q1) | 80.4175.62 | 88.66 | -14.71% (-13.04) | |
| Feb 10, 2025 | 2024 (Q4) | 74.8074.13 | 78.23 | -5.24% (-4.10) | |
| Nov 04, 2024 | 2024 (Q3) | 75.9581.58 | 75.99 | 7.35% (+5.59) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
